ONEMEDNET CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ONEMEDNET CORPORATION (ONMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-08
- ONEMEDNET CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- ONEMEDNET CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 511.44M shares, a 2045660.00% increase from fiscal 2021.
- ONEMEDNET CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00 shares S-1/A · filed 2026-07-08 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-04-15 | |
| 2022-12-31 | 511.44M shares 10-K/A · filed 2024-11-05 | 577.00K shares 10-K · filed 2024-04-09 |
| 2021-12-31 | 25.00K shares 10-K · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |